| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$62 |
Change of Director's Interest Notice
|
23 Jan 2026 9:08AM |
$0.084 |
$0.087 |
risen by
3.57%
|
|
| 360 Capital Mortgage REIT (TCF) ORDINARY UNITS FULLY PAID |
Financials |
$52 |
Dividend/Distribution - TCF
|
23 Jan 2026 9:08AM |
$5.780 |
$5.800 |
risen by
0.35%
|
|
| Elementos Limited (ELT) ORDINARY FULLY PAID |
Materials |
$152 |
Tungsten and Rubidium extensions at Cleveland Project
|
23 Jan 2026 9:07AM |
$0.380 |
$0.350 |
fallen by
7.89%
|
|
ELT - Price-sensitive ASX Announcement
Full Release
Key Points
- Elementos Limited (ASX: ELT) is re-evaluating the Cleveland Project for its potential in tin, tungsten, and critical minerals.
- New assays from historical drill core have identified additional tungsten, rubidium, and bismuth mineralization.
- A tungsten Mineral Resource Estimate update is expected by February 2026.
- Successful ore sorting tests have led to planned metallurgical tests for mineral recovery.
- Price indications for tungsten APT and rubidium carbonate have been provided.
- Drill hole C1570 has shown significant tungsten and rubidium mineralization.
- The project aims to assess dual-phase mining potential covering tin-copper and tungsten-critical minerals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$99 |
BB1 Presents at Simons Foundation Autism Research Initiative
|
23 Jan 2026 9:07AM |
$0.950 |
$0.785 |
fallen by
17.37%
|
|
| Teaminvest Private Group Limited (TIP) ORDINARY FULLY PAID |
Financials |
$33 |
Ceasing to be a substantial holder for CIW
|
23 Jan 2026 9:07AM |
$1.620 |
$1.220 |
fallen by
24.69%
|
|
| Clime Investment Management Ltd (CIW) ORDINARY FULLY PAID |
Financials |
$26 |
Ceasing to be a substantial holder from TIP
|
23 Jan 2026 9:07AM |
$0.385 |
$0.320 |
fallen by
16.88%
|
|
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$36 |
Trading Halt
|
23 Jan 2026 9:05AM |
$0.041 |
$0.030 |
fallen by
26.83%
|
|
DVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Dorsavi Ltd requested a trading halt.
- The halt is related to a Development Collaboration Agreement for RRAM Technology.
- The trading halt is in accordance with ASX Listing Rule 17.1.
- The halt will be lifted by 28 January 2026 or upon the announcement release.
- The company aims to manage continuous disclosure obligations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ovanti Limited (OVT) ORDINARY FULLY PAID |
Communication Services |
$10 |
Application for quotation of securities - OVT
|
23 Jan 2026 9:04AM |
$0.002 |
$0.022 |
risen by
1,000%
|
|
| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$10 |
Exceptional Gold Met Recoveries Average 92.75% at Korong MRE
|
23 Jan 2026 9:04AM |
$0.024 |
$0.020 |
fallen by
16.67%
|
|
VRL - Price-sensitive ASX Announcement
Full Release
Key Points
- High gold recoveries averaging 92.75% at Korong.
- Best-case recoveries reached 98.1% for fresh high-grade material.
- Consistent performance across near-surface regolith domains.
- Low reagent consumption supports efficient processing.
- Results support conventional gravity and cyanide leaching methods.
- Testwork enhances confidence in mine planning and resource upgrade.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Strickland Metals Limited (STK) ORDINARY FULLY PAID |
Materials |
$553 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
23 Jan 2026 9:03AM |
$0.215 |
$0.210 |
fallen by
2.33%
|
|
STK - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities during the December Quarter focused on drilling at Gradina, Shanac, and Kotlovi projects.
- Significant gold and zinc intercepts were identified, particularly at the Gradina site.
- The Company used a formula to calculate gold equivalent (AuEq) grades based on the prices and recovery rates of gold, copper, silver, lead, and zinc.
- The document includes intercept data for various drill holes such as ZRSD25208 and ZRSD25212, highlighting significant mineralization zones.
- Exploration at Shanac and Kotlovi also yielded notable results with high-grade gold and copper zones.
- The report provides detailed tables of significant intercepts and their corresponding grades for each project site.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$62 |
Notification of cessation of securities - NUZ
|
23 Jan 2026 9:02AM |
$0.084 |
$0.087 |
risen by
3.57%
|
|
| Miramar Resources Limited (M2R) ORDINARY FULLY PAID |
Materials |
$6 |
Change in substantial holding
|
23 Jan 2026 9:02AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$10 |
Emerging Growth Conference Presentation
|
23 Jan 2026 9:02AM |
$0.037 |
$0.032 |
fallen by
13.51%
|
|
| Liberty Metals Ltd (LIB) ORDINARY FULLY PAID |
Materials |
$33 |
HIGH-GRADE MONAZITE INDICATES DISTRICT-SCALE REE AT PARAIBA
|
23 Jan 2026 9:01AM |
$0.005 |
$0.004 |
fallen by
20%
|
|
LIB - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade monazite mineralization discovered in Paraiba.
- Significant concentrations of Neodymium and Praseodymium identified.
- Potential for district-scale rare earth element resources.
- Geological setting similar to successful models in Cameroon.
- Project located in established mineral sands region in Brazil.
- Further exploration and processing studies planned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,130 |
GYG announces Strategic Partnership with Uber
|
23 Jan 2026 9:01AM |
$22.440 |
$21.040 |
fallen by
6.24%
|
|
GYG - Price-sensitive ASX Announcement
Full Release
Key Points
- GYG announces an exclusive delivery partnership with Uber Eats.
- The partnership starts from 22 February 2026.
- Uber Eats will be GYG's exclusive delivery partner in Australia.
- The partnership aims to strengthen the delivery channel's economics.
- The exclusivity only applies to Australia.
- Delivery accounts for about 27% of GYG's total sales in Australia.
- 1H26 results will be released on 20 February 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,681 |
Net Tangible Asset Backing
|
23 Jan 2026 9:00AM |
$4.250 |
$4.230 |
fallen by
0.47%
|
|
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$57 |
Notice pursuant to Section 203D of the Corporations Act
|
23 Jan 2026 9:00AM |
$0.056 |
$0.052 |
fallen by
7.14%
|
|
| Super Retail Group Limited (SUL) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,861 |
Investor Conference Call Details for FY26 Half Year Results
|
23 Jan 2026 8:56AM |
$14.650 |
$12.670 |
fallen by
13.52%
|
|
| Apostle Dundas Global Equity Fund (ADEF) |
Financials |
$15 |
Monthly Factsheet - December 2025
|
23 Jan 2026 8:56AM |
$6.300 |
$5.780 |
fallen by
8.25%
|
|
| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$227 |
Quarterly Cashflow Report - December 2025
|
23 Jan 2026 8:54AM |
$0.165 |
$0.230 |
risen by
39.39%
|
|
SKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Sky Metals Limited reported a net cash outflow from operating activities of $449,000 for the current quarter.
- Investing activities resulted in a net cash outflow of $1,464,000, primarily due to significant exploration and evaluation expenditures.
- Financing activities provided a net cash inflow of $592,000, largely from the issuance of equity securities.
- The company ended the period with cash and cash equivalents of $4,701,000.
- Payments to related parties included $54,000 for directors and consulting fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,468 |
Update - Notification of buy-back - FLT
|
23 Jan 2026 8:53AM |
$15.500 |
$11.830 |
fallen by
23.68%
|
|
| Franklin Australian Absolute Return Bond Fund (Managed Fund) (FRAR) |
Financials |
$722 |
Indicative Distribution Calendar 31 January 2026
|
23 Jan 2026 8:52AM |
$1.045 |
$1.045 |
fallen by
0%
|
|
| Delta Lithium Limited (DLI) ORDINARY FULLY PAID |
Materials |
$165 |
Lithium Exploration Update
|
23 Jan 2026 8:52AM |
$0.290 |
$0.230 |
fallen by
20.69%
|
|
DLI - Price-sensitive ASX Announcement
Full Release
Key Points
- Mt Ida project contains advanced lithium, tantalum, and rubidium resources.
- Total JORC MRE at Mt Ida is 14.8Mt at 1.2% Li2O.
- Successful production of 99.8% lithium carbonate from Mt Ida mica concentrate.
- Yinnetharra Lithium Project spans over 2,300 km².
- Yinnetharra MRE is 21.9Mt at 1.0% Li2O.
- Current exploration programs are ongoing with significant lithium intercepts.
- Delta's cash balance is $54 million as of 31 December 2025.
- Additional investments valued at $145 million as of 20 January 2026.
- Continued focus on exploration and development in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$152 |
Quarterly Activities Report and Appendix 4C
|
23 Jan 2026 8:52AM |
$0.935 |
$0.620 |
fallen by
33.69%
|
|
NYR - Price-sensitive ASX Announcement
Full Release
Key Points
- HREC approval received for Phase IIa clinical trial of Xolatryp®.
- Patient recruitment for clinical trial to start in March 2026.
- AU$7.12 million cash balance as of 31 December 2025.
- Expected R&D tax rebate of AU$2.16 million for FY2025.
- Phase IIa trial to assess safety and preliminary efficacy in heart attack patients.
- Initiation of preclinical studies for oncology indications.
- Trademark granted for Xolatryp in medicinal and health services.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$94 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Jan 2026 8:51AM |
$0.090 |
$0.078 |
fallen by
13.33%
|
|
ALA - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash and cash equivalents at 31 December of $19.4 million.
- IND application for ALA-101 submitted to U.S. FDA.
- Preparation for first-in-human phase 1 trial for ALA-101 initiated.
- Demonstrated activity of CLDN18.2-targeting CAR for ALA-105.
- In-licensing additional CAR targets and technology from Baylor College of Medicine.
- Appointment of Dr. Andrew Nash as a Non-Executive Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.